Long-term adherence to therapy: The clue to prevent hypertension consequences

European Heart Journal

Volumn 34, Issue 38, 2013, Pages 2931-2932

  Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CAREGIVER; CEREBROVASCULAR ACCIDENT; COST; DEATH; DOCTOR PATIENT RELATION; EDITORIAL; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCOME; INFORMATION; LIFESTYLE MODIFICATION; LONG TERM CARE; MEMORY DISORDER; MENTAL DISEASE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; PROPHYLAXIS; RISK; RISK FACTOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG COST; DRUG DOSE REGIMEN; DRUG SAFETY; FAMILY; KIDNEY INJURY;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; STROKE;

EID: 84886044020     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht299     Document Type: Editorial

References (7)

1. The GBDSconsortium. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study. Lancet 2012;380:2095-2128.
2. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominczak A, Galderisi M, Grobbee D, Jaarsma T, Kirchof P, Kjeldsen S, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PE, Sleight P, Viigima M, Waeber B, Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-2219.
3. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RCM, Coker-Schwimmer EJL, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self administered medications for chronic diseases in United States. Ann Intern Med 2012;157:785-795.
4. Herttua K, Tabák AG, Martikainen P, Vahtera J, Kivimäki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: Population-based study. Eur Heart J 2013;34:2933-2939.
5. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A. Outcomes in hypertensive patients at high cadiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004;363:2022-2031.
6. Ruilope LM. Current challenges in the clinical management of hypertension. Nat Rev Cardiol 2012;9:267-275.
7. Karmall KN, Lloyd-Jones DM. Adding a life-course perspective to cardiovascular risk communication. Nat Rev Cardiol 2013;10:111-115.